Université de Sherbrooke and deutraMed, a KEY DH Technologies’ Subsidiary, Accelerate $500,000 mRNA Vaccine Stabilization Technology Project

Posted on May 21, 2021 Collaboration seeks to alleviate cold storage requirements for mRNA COVID vaccines, enhance other medical therapeutics (Sherbrooke, Que. and Collingwood, Ont., May 21, 2021) – Université de Sherbrooke and KEY DH Technologies Inc. subsidiary deutraMed Inc. today announced a collaboration to accelerate the development of deutraMed’s innovative Biomolecule Stabilization Technology platform. The… Continue reading →

    Start the Conversation